Stocks Making Significant Moves Midday: Vestis Surges Over 30%, Under Armour Slides 18%, and ZoomInfo Technologies Drops 33%
Several companies experienced significant stock movements based on their recent earnings reports and guidance updates.
Hims & Hers Health
Price: 27.78Company and Business Model
Hims & Hers Health is a healthcare company that provides telehealth services and wellness products, focusing on personal health and wellness solutions. Its core offerings include prescription medications, over-the-counter products, and health consultations, primarily targeting issues such as sexual health, hair loss, and skincare. The company operates through direct-to-consumer channels, generating revenue from subscription services and product sales.
Investment Profile
The investment profile of Hims & Hers Health is more aligned with growth investors, given its focus on expanding its service offerings and market reach. The company currently does not provide dividends and has shown volatility in its earnings. Investors should consider the potential for future growth against the backdrop of higher risk factors.
Fundamental metrics (experimental)
- EPS (TTM) — earnings per share for the last 12 months, $
- -0.05 Risk
- Revenue QoQ — quarter-over-quarter revenue growth
- -1.6% ≈
- EPS surprise
- -550.0% worse than expected
- 20d volatility
- 5.1% normal
FMP / FinFeed data updated:
2026-06-09
Forecast impact
neutral
Target Lowered
· UBS
· valid until 2026-06-25
· updated 2026-06-11
Target
-10.0%
target fill 111.1%
Reaction
D5 -15.83% · D10 -12.01%
Impact
Potential 0
·
Risk 0
up to 30 days or until target is reached
Reco: Sell
Potential: 32
Risk: 69
Updated: 2026-06-11 05:20
How recommendation works
Why AI thinks so:
Weak fundamentals and negative momentum raise significant concerns.
Track in portfolio
Price chart
AI recommendation
Analyst forecast
Calendar event
Positive signal
Negative signal
Neutral / update
Hold / informational
B My buy
S My sell
AI recommendation changes
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-05-30 02:41 | Hold | Sell | Weak fundamentals and high volatility raise significant concerns. |
| 2026-05-14 03:36 | Buy | Hold | Weak momentum and high risk; uncertain growth outlook. |
| 2026-05-10 02:33 | Hold | Buy | Strong momentum and positive EPS surprise indicate growth potential. |
Analyst forecasts
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-06-02 12:19 | Leerink Partners | Update | — → 25 | 27.635 |
| 2026-05-26 09:25 | UBS | Target Lowered | — → 25 | 23.75 |
| 2026-05-22 14:00 | UBS | Target Raised | 18 → 23 | 23.88 |
Stocks to Watch: Under Armour Reports Loss, GameStop Shares Drop After eBay Rejection, and Wendy’s Rallies on Buyout Speculation
Under Armour's shares fell 14% after the company reported a loss of 3 cents per share on revenue of $1.17 billion, which was below analysts' expectations of a loss of 2 cents on revenue of $1.68 billion.
Hims & Hers (HIMS) Shares Drop 15% Following First-Quarter Loss and Weak Earnings Guidance
Hims & Hers, a telehealth company, experienced a significant decline in its stock price, dropping 15.5% in premarket trading following the release of its first-quarter earnings report.
Stock Futures Remain Steady as Traders Anticipate Inflation Data and Monitor Developments in Iran Conflict
These are the stocks moving the most in extended-hours trading: Hims & Hers Health — Shares dropped more than 12% after the telehealth company guided for adjusted EBITDA in its current quarter of between $35 million to $55 million.
Stocks Decline After Hours: Hims & Hers Health, Webtoon Entertainment, and Gitlab Report Disappointing Earnings Guidance
After hours trading saw significant movements in several companies.
Hims & Hers (HIMS) может получить выгоду от политики пептидов Роберта Кеннеди-младшего, так как развивается бизнес GLP-1
Компания Hims & Hers Health, занимающаяся телемедициной, увидела рост акций после объявления министра здравоохранения Роберта Ф.
Акции Hims & Hers Health (HIMS) выросли на 3% после повышения рейтинга Bank of America до нейтрального, в то время как BioNTech (BNTX) упали более чем на 20% из-за ухода соучредителей
На фондовом рынке произошли значительные изменения в акциях нескольких компаний.
Акции Hims & Hers (HIMS) выросли на 39% после заключения сделки с Novo Nordisk, а акции Xenon Pharmaceuticals (XENE) подскочили более чем на 47% после успешного испытания препарата
На фондовом рынке наблюдаются значительные колебания акций различных компаний.
Акции Hims & Hers (HIMS) выросли на 50% после того, как Novo Nordisk (NVO) отказался от иска о нарушении патента
Novo Nordisk прекратил судебный процесс против компании Hims & Hers по делу о нарушении патентов, после того как обе компании договорились о продаже препаратов Novo через платформу Hims.
Акции Hims & Hers Health (HIMS) выросли после заключения сделки с Novo Nordisk, Live Nation Entertainment (LYV) поднялись на 9% на фоне близости соглашения с Минюстом
На фоне продолжающегося конфликта в Иране, цены на нефть резко возросли, что положительно сказалось на акциях нефтяных компаний.